BML Capital Management LLC trimmed its stake in Disc Medicine Opco Inc (NASDAQ:IRON – Get Rating) by 58.4% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 208,161 shares of the company’s stock after selling 291,839 shares during the quarter. Disc Medicine […]
Disc Medicine Opco Inc (NASDAQ:IRON – Get Rating) shares reached a new 52-week high during trading on Thursday . The company traded as high as $57.70 and last traded at $55.76, with a volume of 111607 shares. The stock had previously closed at $53.34. Wall Street Analysts Forecast Growth IRON has been the subject of […]
Shares of Disc Medicine Opco Inc (NASDAQ:IRON – Get Rating) have earned an average recommendation of “Buy” from the ten ratings firms that are currently covering the firm, MarketBeat Ratings reports. Nine analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12 […]
Disc Medicine Opco (NASDAQ:IRON – Get Rating) and Pliant Therapeutics (NASDAQ:PLRX – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings. Analyst Recommendations This is a summary of recent […]
Disc Medicine Opco (NASDAQ:IRON – Get Rating) had its target price boosted by Cantor Fitzgerald from $45.00 to $65.00 in a report released on Friday, The Fly reports. IRON has been the subject of a number of other reports. BMO Capital Markets assumed coverage on Disc Medicine Opco in a report on Thursday, March 23rd. […]